RNF2 induces myeloid-derived suppressor cells chemotaxis and promotes hepatocellular carcinoma progression through the TRAF2-NF-κB signaling axis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.RING finger protein 2 (RNF2) promotes liver cancer growth by creating an immunosuppressive tumor microenvironment. Targeting RNF2 may improve immunotherapy response in hepatocellular carcinoma.
Area Of Science
- Oncology
- Immunology
- Molecular Biology
Background
- RING finger protein 2 (RNF2) is implicated in tumor growth across various cancers.
- The specific role of RNF2 in regulating the tumor microenvironment, particularly in hepatocellular carcinoma (HCC), remains largely undefined.
- Understanding RNF2's immune regulatory function is crucial for developing novel cancer therapies.
Purpose Of The Study
- To investigate the role of RNF2 in hepatocellular carcinoma progression and its impact on the tumor microenvironment.
- To elucidate the molecular mechanisms by which RNF2 influences immune cell populations and function within HCC.
- To evaluate the therapeutic potential of targeting RNF2 in combination with immunotherapy.
Main Methods
- Correlation analysis of RNF2 expression with tumor burden and patient prognosis in HCC.
- Investigation of RNF2's interaction with TRAF2 and its effect on TRAF2 ubiquitination and NF-κB signaling.
- Assessment of RNF2's role in myeloid-derived suppressor cells (MDSCs) recruitment and T cell activation.
- Evaluation of RNF2 knockout effects on anti-PD-1 therapy response in immunocompetent mouse models.
Main Results
- Upregulated RNF2 correlates with increased tumor burden and poor prognosis in HCC patients.
- RNF2 promotes an immunosuppressive microenvironment by increasing MDSC recruitment and decreasing T cell activation.
- Mechanistically, RNF2-mediated TRAF2 ubiquitination leads to NF-κB hyperactivation and CXCL1 induction, enhancing MDSC migration.
- RNF2 knockout significantly improves responsiveness to anti-PD-1 therapy, increasing CD8+ T cell infiltration and reducing MDSCs.
Conclusions
- RNF2 plays a critical role in fostering an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Targeting RNF2, potentially in conjunction with strategies to deplete MDSCs, presents a promising therapeutic avenue for HCC interception and prevention.
- Modulating RNF2 could enhance the efficacy of existing immunotherapies like anti-PD-1 treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...